Skip to main content
Equibles
OMDA logo

OMDA · Omada Health, Inc.

Track OMDA — free

Use OMDA with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about OMDA

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$23.67 -0.60 (-2.47%)
Russell 2000 member Rebalance outlook locked
Market Cap
$1.49B
Shares
61.22M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$24.27 Open$24.32 Day$24.15–25.45 52W close$10.94–26.78 Avg vol 30d1.4M Short int5.9M · 9.6% float · 3.1d Short vol31% Last earningsAug 6, 2026 DataJun 2025–Aug 2026 Filing10-Q · Aug 7

Up next

Next earnings call
Nov 5, 2026 Est · unconfirmed · in 10 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 7, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Buy
      SellHoldBuy
      Technical Buy Momentum Very Strong Sentiment Bullish Fundamentals Excellent Quant / Vol Very High
      Market backdrop VIX 14.5 · calm Equity put/call 0.39
      Technical
      price trend
      Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +44%
      above
      Price vs 50-day avg +10%
      above
      RSI (14) 61
      neutral
      MACD trend Positive
      52-week position 84%
      mid-range
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Very Strong
      1-month return +23%
      trailing
      6-month return +73%
      trailing
      YTD return +54%
      this year
      Relative strength +58%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bullish
      Trend (MA cross) No cross
      50d $22 › 200d $17 — 50d above 200d
      Institutional flow Accumulating
      +9% holders QoQ · +35 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      9.62% of float · ▼ -22.8% MoM · 3.1 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      153 holders — near 1-yr high, broad support
      Squeeze score 67
      elevated · 0–100
      Fundamentals
      Excellent
      Revenue growth +53%
      Y/Y
      Gross margin 66%
      expanding
      EPS growth +94%
      Y/Y
      Free cash flow $16.9M
      Balance sheet $222.0M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 59%
      annualized · 1-yr
      Max drawdown −59%
      past year
      ATR 4.5%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed Aug 6, 2026
      Revenue · year ending December 31, 2026 Maintained $334M – $340M
      Jun 30, 2026 $334M – $340M changed to Aug 6, 2026 $334M – $340M
      prior FY $260.21M midpoint +29.5% Y/Y
      Adjusted EBITDA · year ending December 31, 2026 Non-GAAP Raised $21M – $27M
      May 7, 2026 $14M – $20M changed to Aug 6, 2026 $21M – $27M
      Prior guidance period ended · from the 8-K filed Jan 12, 2026
      Preliminary, unaudited revenue · fourth quarter of 2025 $72M – $74M
      Preliminary revenue · full year 2025 $256M – $258M
      Guided vs delivered · last 1 settled
      Revenue year ending December 31, 2025
      guided $251.5M – $254.5M
      $260.21M Beat +2.8%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      0 · 4 · 3
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +44% Bullish
      Price vs 50-day avg
      +10% Bullish
      RSI (14)
      61 Neutral
      MACD trend
      Positive Bullish
      52-week position
      84% Neutral
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bullish · 3 of 6
      Trend (MA cross) No cross
      50d $22 › 200d $17 — 50d above 200d
      Institutional flow Accumulating
      +9% holders QoQ · +35 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      9.62% of float · ▼ -22.8% MoM · 3.1 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      153 holders — near 1-yr high, broad support
      Price context
      position in its 52-week range
      Range low $11 Now $24 · 84% Range high $27
      vs 200-day avg +44% vs 50-day avg +10%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      GAAP → non-GAAP reconciliation
      GAAP GAAP net income (loss) and comprehensive income (loss) 5.29M
      +14K Interest expense
      -1.76M Interest income
      +0K Change in fair value of warrant liabilities
      +0K Loss on debt extinguishment
      +0K Provision for income taxes
      +5.63M Share-based compensation expense
      +439K Amortization of intangible assets
      +1.14M Depreciation and amortization
      +25K Loss on disposal of property and equipment
      = Adjusted EBITDA 10.79M
      GAAP → non-GAAP reconciliation
      GAAP Net cash used in operating activities -11.83M
      -78K Purchases of property and equipment
      -1.48M Capitalized internal-use software costs
      = Free Cash Flow -13.39M
      Gross margin 62% first quarter —
      Non-GAAP gross profit non-GAAP $50.17M Three Months Ended March 31, 2026 —
      GAAP → non-GAAP reconciliation
      GAAP GAAP gross profit 48.69M
      +62K Share-based compensation expense
      +439K Amortization of intangible assets
      +980K Depreciation and amortization
      = Non-GAAP gross profit 50.17M
      Non-GAAP general and administrative expense (as a % of revenue) non-GAAP 17% Year Ended December 31 —
      Non-GAAP operating expense (as a % of revenue) non-GAAP 65.2% Year Ended December 31 —
      Non-GAAP research and development expense (as a % of revenue) non-GAAP 15% Year Ended December 31 —
      Non-GAAP sales and marketing expense (as a % of revenue) non-GAAP 33% Year Ended December 31 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Health Information Services — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      OMDA
      Omada Health, Inc.
      this stock
      		$1.49B +53.8% +53.2% — 9.6%
      VEEV
      Veeva Systems Inc
      		 $44.80B +26.4% +28.1% 45.3 3.6%
      PMDIY
      Pro Medicus Ltd./ADR
      		 $13.02B -24.9% — — 0.0%
      BTSG
      BrightSpring Health Services, Inc.
      		 $12.25B +62.6% +28.2% 37.5 4.5%
      TEM
      Tempus AI, Inc.
      		 $11.56B +19.7% +83.4% — 16.6%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      153
      % held
      89.6%
      Net QoQ
      +5.4M sh
      Top holder
      Revelation Capital Manage…
      Held Float
      View
      Held by Funds
      Fund positions
      122
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      5.9M
      Days to cover
      3.1d
      Change
      -1.7M sh
      View
      Short Volume
      Short vol %
      31%
      As of
      Aug 28, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      1
      Value
      $20
      As of
      Jul 29, 2026
      View
      Off-Exchange
      Off-exchange %
      31.4%
      Week of
      Jul 20, 2026
      Off-exch Lit
      View
      Financials
      Financials
      Revenue (FY)
      $260.2M
      Net income (FY)
      $-12.8M
      EPS diluted
      $-0.35
      View
      Filings
      SEC Filings
      Latest
      Investor Event Transcript
      Filed
      Aug 11, 2026
      This year
      11
      View
      Proposed Sales
      Value
      $212.9K
      Shares
      8.9K
      Filed
      Aug 12, 2026
      View
      Earnings & Events
      Earnings Calls Upcoming
      Next call
      Sep 10, 2026
      Last call
      Aug 11, 2026
      View
      Investor Relations
      Upcoming events
      1
      View

      Performance

      5D 20D 120D MTD YTD
      OMDA +2.4% +23.3% +72.7% +22.3% +53.8%
      SPY +1.1% +4.0% +14.7% +3.2% +13.1%
      vs SPY +1.3% +19.3% +58.1% +19.1% +40.7%
      Key facts CIK 1611115 CUSIP 68170A108 13F (30d) 134 filings 133 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)